Getting pregnant in HIV clinical trials: women’s choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials

References

• Bongaarts J, Casterline J. Fertility transition: is sub-saharan Africa different? Popul Dev Rev. 2013;38(Suppl. 1):153–168.10.1111/padr.2013.38.issue-s1
   PubMed Web of Science ®Google Scholar
• Ferry B, Desgrées du Loû A. Sexualité et procréation confrontées au sida dans les pays du Sud [Sexuality and Procreation Facing AIDS in Developing Countries]. Paris: Les collections du CEPED; 2006.
   Google Scholar
• Nebié Y, Meda N, Leroy V, et al. Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso. J Acquir Immune Defic Syndr. 2001;28(4):367–372.
   PubMed Web of Science ®Google Scholar
• Zaba B, Gregson S. Measuring the impact of HIV on fertility in Africa. AIDS Lond Engl. 1998;12(Suppl. 1):S41–50.
   PubMed Web of Science ®Google Scholar
• Ross A, Van der Paal L, Lubega R, et al. HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS. 2004;18(5):799–804.10.1097/00002030-200403260-00012
   PubMed Web of Science ®Google Scholar
• Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105(8):836–848.10.1111/bjo.1998.105.issue-8
   PubMedGoogle Scholar
• Myer L, Carter RJ, Katyal M, et al. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in sub-saharan Africa: a cohort study. PLoS Med. 2010;7(2):e1000229.10.1371/journal.pmed.1000229
   PubMed Web of Science ®Google Scholar
• Kabami J, Turyakira E, Biraro S, Bajunirwe F. Increasing incidence of pregnancy among women receiving HIV care and treatment at a large urban facility in western Uganda. Reprod. Health. 2014;11:81.10.1186/1742-4755-11-81
   PubMed Web of Science ®Google Scholar
• Gac SL, Coutherut J, Desclaux A, et al. Réalités et enjeux de la participation des femmes dans les essais cliniques sur les antirétroviraux: expérience au Sénégal [Realities and challenges in the participation of women in ART clinical trials: experience in Senegal]. 2011;219–32.
   Google Scholar
• Bussmann H, Wester CW, Wester CN, et al. Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana. J Acquir Immune Defic Syndr. 2007;45(3):269–73.
   PubMed Web of Science ®Google Scholar
• Ciaffi L, Koulla-Shiro S, Sawadogo A, et al. Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa. AIDS. 2015;29(12):1473–1481.10.1097/QAD.0000000000000709
   PubMed Web of Science ®Google Scholar
• Villar J, Cheikh Ismail L, Victora CG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. The Lancet. 2014;384(9946):857–868.10.1016/S0140-6736(14)60932-6
   PubMed Web of Science ®Google Scholar
• Burgos-Soto J, Balestre E, Minga A, et al. Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 West African countries. J Acquir Immune Defic Syndr. 2014;67(2):e45–e54.10.1097/QAI.0000000000000279
   PubMed Web of Science ®Google Scholar
• Institut National de la Statistique et de la Démographie (INSD) [Burkina Faso] et ICF International. Enquête Démographique et de Santé et à Indicateurs Multiples (EDSBF-MICS IV) [Multiple indicators cluster demographic and health survey]. Calverton, MD: INSD et ICF International; 2010.
   Google Scholar
• Agence Nationale de la Statistique et de la Démographie (ANSD) [Sénégal], et ICF International. Enquête Démographique et de Santé Continue (EDS-Continue 2012–2013) [Demographic and Health Survey]. Calverton, MD: ANSD et ICF International; 2012–2013.
   Google Scholar
• Kongnyuy EJ, Wiysonge CS. Association between fertility and HIV status: what implications for HIV estimates? BMC Public Health. 2008;8:309.10.1186/1471-2458-8-309
   PubMed Web of Science ®Google Scholar
• Homsy J, Bunnell R, Moore D, et al. Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One. 2009;4(1):e4149.10.1371/journal.pone.0004149
   PubMed Web of Science ®Google Scholar
• Untangling the relationship between antiretroviral therapy use and incident pregnancy: a marginal structural model analysis using data From 47,313 PubMed – NCBI [Internet]. [cited 2016 Jun 26]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=untangling+the+relationship+between+antiretroviral+therapy+use+and+incident+pregnancy+%3A+a+marginal+structural+model+analysis
   Google Scholar
• Ssali A, Namukwaya S, Bufumbo L, et al. Pregnancy in HIV clinical trials in sub saharan Africa: failure of consent or contraception? PLoS One. 2013;8(9):e73556.10.1371/journal.pone.0073556
   PubMed Web of Science ®Google Scholar
• Lindegger G, Milford C, Slack C, et al. Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa. J Acquir Immune Defic Syndr. 2006;43(5):560–566.
   PubMed Web of Science ®Google Scholar
• Brou H, Viho I, Djohan G, et al. Contraceptive use and incidence of pregnancy among women after HIV testing in Abidjan, Ivory Coast. Rev Dépidémiologie Santé Publique [Epidemiology and public health]. 2009;57(2):77–86.10.1016/j.respe.2008.12.011
   PubMed Web of Science ®Google Scholar
• Gibb DM, Kizito H, Russell EC, et al. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. PLoS Med. 2012;9(5):e1001217.10.1371/journal.pmed.1001217
   PubMed Web of Science ®Google Scholar
• King R, Khana K, Nakayiwa S, et al. ‘Pregnancy comes accidentally – like it did with me’: reproductive decisions among women on ART and their partners in rural Uganda. BMC Public Health. 2011;11:530.10.1186/1471-2458-11-530
   PubMed Web of Science ®Google Scholar
• Cates W, Steiner MJ. Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach? Sex Transm Dis. 2002;29(3):168–174.10.1097/00007435-200203000-00007
   PubMed Web of Science ®Google Scholar
• Anglewicz P, Clark S. The effect of marriage and HIV risks on condom use acceptability in rural Malawi. Soc Sci Med. 2013;97(97):29–40.10.1016/j.socscimed.2013.06.024
   PubMed Web of Science ®Google Scholar
• Massad LS, Springer G, Jacobson L, et al. Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS. 2004;18(2):281–286.10.1097/00002030-200401230-00018
   PubMed Web of Science ®Google Scholar
• Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis. 2012;54(9):1348–1360.10.1093/cid/cis198
   PubMed Web of Science ®Google Scholar
• Powis KM, Kitch D, Ogwu A, et al. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis. 2011;204(4):506–514.10.1093/infdis/jir307
   PubMed Web of Science ®Google Scholar
• Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362(24):2282–2294.10.1056/NEJMoa0907736
   PubMed Web of Science ®Google Scholar